UltraBright Biotech

More signal. Higher sensitivity. Faster assays.

UltraBright Biotech is a German-based biotechnology company dedicated to overcoming the fundamental limitations of signal detection in life sciences and clinical diagnostics. Based in Hallbergmoos, the company specializes in the development of high-performance detection reagents designed to enhance the sensitivity, speed, and accuracy of molecular assays.

The company’s core mission is to provide researchers and diagnostic manufacturers with the tools necessary to detect low-abundance analytes that are often invisible to conventional methods. By bridging the gap between existing diagnostic hardware and the need for higher sensitivity, UltraBright aims to enable earlier disease detection and more reliable patient outcomes.

At the heart of their offering is the proprietary Ultra Beacon platform. This innovative technology allows for the attachment of over 100 signal-generating labels to a single detection probe, resulting in up to a 100-fold increase in signal intensity compared to standard antibodies. This massive amplification occurs without a proportional increase in background noise, ensuring that assays remain both highly specific and incredibly fast.

UltraBright’s solutions are engineered for "plug-and-play" integration, allowing them to be utilized across a vast range of platforms—from flow cytometry and ELISA to lateral flow tests and high-throughput clinical analyzers. By providing a universal boost to detection signals, UltraBright Biotech is helping to set a new standard for performance in laboratory research and point-of-care diagnostics worldwide.